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Abstract
Background: Quality indicators (QIs) are used in many healthcare settings to measure, compare, and improve
quality of care. For the efficient development of high-quality QIs, rigorous, approved, and evidence-based
development methods are needed. Clinical practice guidelines are a suitable source to derive QIs from, but no
gold standard for guideline-based QI development exists. This review aims to identify, describe, and compare
methodological approaches to guideline-based QI development.
Methods: We systematically searched medical literature databases (Medline, EMBASE, and CINAHL) and grey
literature. Two researchers selected publications reporting methodological approaches to guideline-based QI
development. In order to describe and compare methodological approaches used in these publications, we
extracted detailed information on common steps of guideline-based QI development (topic selection, guideline
selection, extraction of recommendations, QI selection, practice test, and implementation) to predesigned
extraction tables.
Results: From 8,697 hits in the database search and several grey literature documents, we selected 48 relevant
references. The studies were of heterogeneous type and quality. We found no randomized controlled trial or other
studies comparing the ability of different methodological approaches to guideline-based development to generate
high-quality QIs. The relevant publications featured a wide variety of methodological approaches to guideline-
based QI development, especially regarding guideline selection and extraction of recommendations. Only a few
studies reported patient involvement.
Conclusions: Further research is needed to determine which elements of the methodological approaches
identified, described, and compared in this review are best suited to constitute a gold standard for guideline-based
QI development. For this research, we provide a comprehensive groundwork.
Background
According to the definition of the Institute of Medicine
(1990), quality of care is the “degree to which health
services for individuals and populations increase the
likelihood of desired health outcomes and are consistent
with current professional knowledge” [1,2]. Increasingly,
quality indicators (QIs) are employed to assess and
improve the quality of care in many healthcare settings
[1,3-5]. QIs are measurable items referring to structures,
processes, and outcomes of care [6]. They imply a judg-
ment on the quality of care provided. However, the
interpretation of such performance assessments can
have far-reaching consequences, for instance, in applica-
tion to pay-for-performance models. Hence, the devel-
opment of QIs should be based on a systematic
approach that ensures transparency and produces high-
quality standards [7]. Important attributes of high-qual-
ity QIs are their relevance to the selected problem and
field of application, their feasibility, and their reliability.
They further need to be easily understandable for provi-
ders and patients, changeable by behavior, achievable,
and measurable with high validity [8,9]. To ensure con-
tent and construct validity, QIs need to be evidence
based and should have a strong correlation with the
actual quality of care provided, respectively [9,10]. The
reliability of QIs in regard to their level of measurement
error can be assessed by an evaluation of the intra- and
inter-observer reliability [11].
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development have been described in several studies
[12-15], and a large body of literature exists evaluating
their strengths and limitations [13,16,17]. However, to
date, no study of which we are aware exists that system-
atically compares different methodological approaches
to QI development with respect to their ability to gener-
ate QIs that improve the quality of the particular health-
care aspects they were designed for.
Developing QIs is an expensive and time-consuming
process. They are usually specific to certain healthcare
settings and, as a result, cannot always be applied to
other settings without an adequate adaption process
[17]. A time-efficient and resource-saving approach is
either to generate QIs from clinical guidelines already
available or to couple the process of guideline develop-
ment with the formulation of appropriate QIs [18,19].
Due to the aim of clinical practice guidelines to improve
quality-of-care processes in practices and care institu-
tions, guideline-based QIs predominantly relate to pro-
cess quality. However, no gold standard exists for
guideline-based QI development [10,20,21].
Blozik et al. [20] recently conducted a survey among
members of the Guideline International Network (G-I-N
[Guidelines International Network, Perthshire, Scot-
land]) that shows that even among working groups spe-
cializing in guideline and QI development, a wide
variety of methodological approaches are used. A gold
standard would help to standardize procedures, foster
transparency, and improve efficiency of resources used.
This review aims to identify, describe, and compare
methodological approaches to guideline-based QI devel-
opment. By pooling the available knowledge and
appraising strengths and limitations, we intend to pro-
vide the groundwork necessary for defining a gold stan-
dard for the development of QIs from clinical practice
guidelines. To achieve this, we addressed the following
research questions:
1. Which methodological approaches to guideline-
based development of QIs have been described so far?
2. What are the strengths and limitations of the meth-
odological approaches described regarding their ability
to generate high-quality QIs?
3. Do methodological approaches to the development
correlate with the quality of QIs they produce?
Methods
We carried out a systematic literature search across
three electronic databases: MEDLINE (US National
Library of Medicine, Bethesda, MD, USA), the Excerpta
Medica database (Embase [Elsevier B.V., New York, NY,
USA]; both via OvidSP
® [Ovid Technologies, Inc., New
York, NY, USA]) to cover articles in medical journals
that are not included in MEDLINE, and the Cumulative
Index to Nursing and Allied Health Literature (CINAHL
[EBSCO Publishing, Ipswich, MA, USA]) to include arti-
cles published in the field of nursing and the allied
health professions. The query date of all three databases
was April 22, 2010. The search included literature from
the earliest records available in the databases up to the
search date. Duplicates were eliminated both manually
and automatically. To identify articles for review, we
linked three search columns using the Boolean operator
“and": quality indicators, guidelines, and development.
We combined several search terms with the Boolean
operator “or” in order to operationalize the search terms
(the MEDLINE search algorithm can be found in Addi-
tional file 1: Table S1 and was slightly adapted for
Embase and CINAHL). We drew several search terms
from the controlled vocabularies used for subject index-
ing in MEDLINE (i.e., Medical Subject Headings
[MeSH]), Embase (i.e., EMTREE), and CINAHL (i.e.,
CINAHL Subject Headings). We searched three data-
bases for ongoing studies (Current Controlled Trials
[Springer Science & Business Media, New York, NY,
USA], HSRProj [Health Services Research Projects in
Progress, US National Library of Medicine, Bethesda,
MD, USA], UKCRN-Portfolio [United Kingdom Clinical
Research Network, National Institute for Health
Research, London, UK] [22]). In addition, we screened
the reference lists of all retrieved publications included
in the final review. From the relevant literature and the
G-I-N database, we derived contact information of insti-
tutions and working groups in the field of guideline and
QI development. We scanned relevant government and
institutional websites in order to obtain web-published
documents such as method papers (for details of web-
sites searched, see Additional file 2: Table S2). Finally,
we consulted colleagues with a research interest in QI
to point out articles not identified during our database,
websites, and reference list search.
Two reviewers independently screened all obtained
references for eligibility in a three-stage screening pro-
cess. Discrepancies were solved by consensus. Articles
were considered for inclusion if they reported at least
one methodological approach to guideline-based QI
development and if they were published in English,
French, or German. All study and publication types
were included.
The detailed reporting of the individual development
steps (see next paragraph) in publications describing
methodological approaches to QI development is indis-
pensable for their reconstruction–be it for the purpose
of process evaluation (as we did) or in order to apply
methodological approaches to QI development in other
settings. We therefore excluded studies at the full-text
screening stage that did not describe the extraction of
recommendations from clinical guidelines in detail, as
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Details of the selection process, including exclusion cri-
teria at the abstract-screening stage, are summarized in
Figure 1.
Two researchers independently extracted data from
the relevant literature to a predesigned data extraction
form (see Additional file 3: Table S3); discrepancies
were solved by consensus. In order to describe and to
compare methodological approaches to guideline-based
QI development, we developed an a priori framework of
the QI development process. For this purpose, we iden-
tified six steps that most methodological approaches to
guideline-based QI development have in common with
regard to function and succession but that differ in their
design from one methodological approach to another.
Through a preliminary search and analysis of a select
number of key publications, we identified six develop-
ment steps: (1) topic selection, (2) guideline selection,
(3) extraction of recommendations, (4) QI selection, (5)
practice test, and (6) implementation (see Figure 2). The
data extraction form was specifically designed to include
(a) information about the methodological approach to
these six development steps and (b) items necessary to
perform a quality assessment of the relevant studies. For
steps 1 to 4, we extracted information about how and
by whom the specific development step was conducted,
such as selection criteria for topics, guidelines, and
recommendations, as well as participants. The two
development steps specific to guideline-based QI devel-
opment (compared to QI development from other
sources) were investigated in more detail, namely, guide-
line selection and extraction of recommendations. In
addition to the above-mentioned selection criteria, we
collected information about the selected guidelines (Was
some sort of quality assessment conducted? Were all
selected guidelines listed in the publication?), as well as
the extracted recommendations (Were they reported at
all? If yes, were the source guideline and the underlying
level of evidence made transparent?). For an overview of
all selected information on guideline selection and
extraction of recommendations, see Table 1.
Due to the wide variety of study and publication types
and the overlap of the quality assessment and the
assessment of methodological approaches, we limited
the quality assessment to items covering funding infor-
mation, the reporting of study and publication type, and
the reporting of duration and time frame of the study.
Following data extraction and identification of the
methodological approaches to each of the above-listed
development steps, we focused on analyzing the similari-
ties and differences among the identified methodological
approaches. The results are presented following further
elaboration of the six development steps introduced
above. We discuss our results in context of the current
literature in the Discussion section.
Results
Search findings and literature selection
We identified a total of 8,697 potentially relevant arti-
cles, of which 8,468 were excluded based on their titles
or abstracts (see Figure 1 for details regarding the
screening process). No additional articles were identified
through expert consultation. We conducted full-text
reviews of the remaining 229 articles and an additional
Figure 1 Flowchart summarizing the screening process.
Figure 2 Overview of the process of guideline-based QI
development.
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literature. The final review included 48 articles.
Of the 48 articles in the final review, 10 papers described
methodological approaches to guideline-based QI develop-
ment in general (referred to as “method papers”)
[1,7,23-30], and 32 articles [31-62] addressed the guideline-
based QI development for a certain clinical topic (referred
to as “topic papers”). An additional six papers [10,19,63-66]
comprised a detailed description of a method as well as its
application for a certain clinical topic (referred to as
“method + topic papers”). None of the selected publica-
tions was a controlled study comparing one development
method to another. All journal articles were published in
English; two of the method papers published via institu-
tional websites [25,26] were written in German.
In not disclosing the funding source and time frame of
the study and in not explicitly reporting the study type,
many of the publications did not meet our basic quality-
assessment criteria (for details, see Table 2).
The identified relevant studies originate from many
different institutions and working groups, only a few of
which have published more than one relevant study on
guideline-based QI development (e.g., the Dutch IQ
healthcare [University of Radbound, Nijmegen, The
Netherlands]).
Tables 2, 3, and 4 provide an overview of the charac-
teristics of all included publications. Figure 3 provides a
comprehensive overview of all methodological
approaches identified.
Unless indicated otherwise, numbers of studies
referred to in the following paragraphs always relate to
all 48 studies of the final review pool.
Topic selection
Criteria for the selection of a clinical topic for QI devel-
opment were detailed in 33 publications. The most fre-
quently reported criteria were
￿ the public health relevance of a topic (mentioned in
18 publications),
￿ the existence of a gap between potential and actually
achieved quality of healthcare (mentioned in 16
publications).
Other reported criteria were uncertainty about the
quality of care provided for a specific healthcare setting
(mentioned in six publications), the economical impact
of a specific healthcare problem (mentioned in six publi-
cations), and the individual impact on the quality of life
(mentioned in four publications).
Guideline selection
In 16 studies, QIs were developed from a single guide-
line, whereas in seven studies more than one guideline
was used to derive QIs. Twenty studies detailed other
sources, such as existing QI databases, in addition to
clinical guidelines.
Only eight of the authors who developed QIs from
more than one source provided a transparent descrip-
tion of the respective sources of final QIs.
Criteria for the selection of guidelines from which the
QIs were derived were reported in 10 publications.
Reported criteria were
￿ the methodological quality,
￿ the up-to-dateness,
￿ the eligibility of a guideline for the selected topic (e.
g., with regard to the specific setting).
In 15 publications a critical appraisal of the used
guidelines was reported based on the Appraisal of
Guidelines Research and Evaluation in Europe (AGREE)
instrument [67] or similar quality criteria.
Whilst participants in guideline selection are often
mentioned, at least indirectly, for instance by being
referred to as “the authors”, criteria for their selection
were reported in only four publications. These selection
criteria were
Table 1 Information extracted relating to guideline selection and extraction of recommendations
Guideline selection Extraction of recommendations
Were QIs developed from
￿ one guideline,
￿ more than one guideline, or
￿ guidelines and other sources?
Were
￿ all recommendations or
￿ a selection of recommendations extracted?
Which criteria for guideline selection were reported? If not all recommendations were extracted, which criteria were reported for
their selection?
Did the authors report a critical appraisal of selected guidelines? Who did extraction recommendations?
Were the selected guidelines listed in the publication? Which criteria were reported for the selection of persons involved in
recommendation extraction?
Who selected the guidelines? Were the extracted recommendations reported in the publication or additional
files available to the reader?
Which criteria were reported for the selection of persons involved
in guideline selection?
Did the authors report sources/levels of evidence of the extracted
recommendations?
QI = quality indicator
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General characteristics Quality assessment
Reference Institution Topic Setting Study/publication
type mentioned
Study
duration
mentioned
Funding
Method papers
ÄZQ (2009) ÄZQ (Berlin, DE) - - No n/a Unclear
AHCPR (1995) AHRQ (Rockville, MD, US) - - No n/a Unclear
AHRQ (1995) AHRQ (Rockville, MD, US) - - Yes - report n/a Combined
public/
private
AQUA (2010) AQUA (Göttingen, DE) - - Yes - method
paper
n/a Unclear
Baker and Fraser
(1995)
Eli Lilly National Clinical Audit
Centre (Leicester, UK)
- - Yes - review n/a Unclear
Bergman (1999) Dept. of Pediatrics, Stanford School
of Medicine (Palo Alto, CA, US)
- - No n/a Unclear
Califf et al. (2002) DCRI (Durham, NC, US) - - Yes - state-of-the-
art paper
n/a Public
Campbell et al.
(2002)
NPCRDC (Manchester, UK) - - Yes - review n/a Unclear
Graham et al.
(2009)
Immpact (Aberdeen, UK) - - Yes - review n/a Public
Spertus et al. (2005) AHA (Dallas, TX, US) - - No n/a Public
Topic papers
Bonow et al. (2005) AHA (Dallas, TX, US) Heart failure Hospital/
outpatient
care
Yes - report No Public
Burge et al. (2007) CCORT (Toronto, CA) Heart failure Primary care No No Public
Campbell et al.
(1999)
NPCRDC (Manchester, UK) CHD, Type 2
Diabetes, Asthma
Primary care Yes - original
article
No Unclear
Desch et al. (2008) RPCI (Buffalo, NY, US) Breast cancer Hospital care Yes - special article No Public
Draskovic et al.
(2008)
IQ healthcare (Nijmegen, NL) Dementia Hospital care No No Public
Estes et al. (2008) AHA (Dallas, TX, US) Atrial fibrillation Outpatient
care
Yes - report No Public
Forbes et al. (1997) KU School of Nursing (Kansas City,
MO, US)
Stroke Rehabilitation No No Public
Giesen et al. (2007) IQ healthcare (Nijmegen, NL) Prescribing and
referral
Emergency
primary care
No No Unclear
Hadorn et al. (1996) RAND (Santa Monica, CA, US) Heart failure Primary care Yes - article No Combined
public/
private
Hardy and Hadley
(1995)
CCQE (Washington, DC, US) Pain All No No Unclear
Hermanides et al.
(2008)
IQ healthcare (Nijmegen, NL) Urinary tract
infection
Hospital care Yes - major article No Unclear
Hermens et al.
(2006)
IQ healthcare (Nijmegen, NL) Lung cancer Hospital care Yes - article No Public
James et al. (1997) Office of Rural Health (Buffalo, NY,
US)
Heart failure Primary care Yes - paper No Public
Kongnyuy and van
den Broek (2008)
LSTM (Liverpool, UK) Perinatal care Hospital care Yes - research
article
No Combined
public/
private
Krumholz et al.
(2006)
AHA (Dallas, TX, US) Myocardial infarction Hospital care Yes - report No Public
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Lee et al. (2003) CCORT (Toronto, CA) Heart failure Hospital/
outpatient
care
Yes - clinical study No Public
MacLean et al.
(2004)
RAND (Santa Monica, CA, US) Rheumatoid arthritis All Yes - original
article
No Unclear
Martirosyan et al.
(2008)
IQ healthcare (Nijmegen, NL) Type 2 Diabetes Primary care Yes - original
research
No Public
Mourad et al.
(2007)
IQ healthcare (Nijmegen, NL) Subfertility care All No No Public
Nijkrake et al.
(2009)
IQ healthcare (Nijmegen, NL) Parkinson’s disease Physiotherapy No No Public
Ouwens et al.
(2007)
IQ healthcare (Nijmegen, NL) Head and neck
cancer
Cross-sectoral
care
Yes - original
article
No Public
Ouwens et al.
(2010)
IQ healthcare (Nijmegen, NL) Patient-centered care All Yes - original
article
No Unclear
Radtke et al. (2009) CVderm (Hamburg, DE) Psoriasis vulgaris All Yes - original
paper
No Unclear
Redberg et al.
(2009)
AHA (Dallas, TX, US) Cardiovascular
prevention
All Yes - report No Public
Schouten et al.
(2005)
IQ healthcare (Nijmegen, NL) Pneumonia Hospital care yes - major article No unclear
Sugarman et al.
(2003)
Qualis Health (Seattle, WA, US) Dialysis All Yes - special article Yes Public
Thomas et al.
(2007)
AHA (Dallas, TX, US) Cardiovascular
diseases
Rehabilitation No No Public
Tu et al. (2008) CCORT (Toronto, CA) Myocardial infarction Hospital care Yes - review No Public
van den Boogaard
et al. (2010)
IQ healthcare (Nijmegen, NL) Miscarriage All Yes - article No Public
van Hulst et al.
(2009)
IQ healthcare (Nijmegen, NL) Rheumatoid arthritis All Yes - extended
report
No Unclear
Wang et al. (2006) RAND (Santa Monica, CA, US) Preterm birth Outpatient
care
Yes - article No Public
Yazdany et al.
(2009)
UCSF (San Francisco, CA, US) Lupus
erythematodes
All Yes - original
article
No Unclear
Method + topic
papers
Advani et al. (2003) BMIR (Stanford, CA, US) Hypertension All No No Public
Duffy et al. (2005) APIRE (Arlington, VA, US) Bipolar disorder Outpatient
care
No No Unclear
Golden et al. (2008) UAMS (Little Rock, US) Bipolar disorder Outpatient
care
No No Public
Hutchinson et al.
(2003)
ScHARR (Sheffield, UK) CHD Primary care Yes - original
paper
Yes Combined
public/
private
LaClair et al. (2001) VA Medical Center (Kansas City, MO,
US)
Stroke Rehabilitation No No Public
Wollersheim et al.
(2007)
IQ healthcare (Nijmegen, NL) Oncology, Type 2
Diabetes, pneumonia
All Yes - review article No Unclear
ÄZQ = Ärztliches Zentrum für Qualität in der Medizin (Agency for Quality in Medicine); AHCPR = Agency for Healthcare Policy and Research; AHRQ = Agency for
Healthcare Research and Quality; AQUA-Institute = Institute for Applied Improvement and Research in Health Care; DCRI = Duke Clinical Research Institute;
NPCRDC = National Primary Care Research and Development Council; Immpact = Initiative for Maternal Mortality Programme Assessment; CCORT = Canadian
Cardiovascular Outcomes Research Team; CHD = coronary heart disease; RPCI = Roswell Park Cancer Institute; AHA = American Heart Association; CCQE = Center
for Clinical Quality Evaluation; LSTM = Liverpool School of Tropical Medicine; CVderm = Competenzzentrum Versorgungsforschung in der Dermatologie (Institute
for Health Services Research in Dermatology); UCSF = University of California, San Francisco; BMIR = Center for Biomedical Informatics Research; APIRE =
American Psychiatric Institute for Research and Education; UAMS = University of Arkansas for Medical Sciences; ScHARR = School of Health and Related Research.
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Topic/guideline selection Extraction of recommendations
Reference Criteria for
selection of
topic
Development
of QI from...
Criteria for
selection of
participants
Criteria for
selection of
guidelines
Participants
listed
a
Critical appraisal Guidelines
listed
a
Extraction of all/
a selection of
recommendations
Criteria for
recommendation
selection
b
Potential
indicators
listed
a
Method
papers
ÄZQ (2009) No One guideline No No - No - Unclear - -
AHCPR
(1995)
No One guideline Yes
Profession
involved in the
selected
healthcare
process,
methodological
competence
Yes
Methodological
quality
- Yes
Not detailed
- Selection Yes
Impact on patient
outcome
-
AHRQ (1995) Yes
Regulatory
requirements,
quality gap,
guideline
adherence
unknown
More than
one guideline
No Yes
Methodological
quality
- Yes
Not detailed
- Selection Yes
Impact on patient
outcome and relevance
to obtaining value for
money
-
AQUA (2010) Yes
Public health
relevance, sound
evidence base,
feasibility
Guidelines
and other
sources
No Yes
Methodological
quality
- Yes
AGREE Instrument
- All - -
Baker and
Fraser (1995)
No Not specified
(method
paper)
No No - Yes
Not detailed
- Unclear - -
Bergman
(1999)
Yes
Sound evidence
base
Not specified
(method
paper)
No No - Yes
Not detailed
- Unclear . -
Califf et al.
(2002)
No One guideline No No - Yes
Not detailed
- Selection Yes
Level of evidence
-
Campbell et
al. (2002)
No Not specified
(method
paper)
No No - No - Unclear - -
Graham et
al. (2009)
Yes
Quality gap
Guidelines
and other
sources
No No - No - Unclear - -
Spertus et al.
(2005)
No Not specified
(method
paper)
No Yes
Strength of
evidence,
clinical
relevance,
magnitude of
relationship
between
performance
and outcome
- Yes
Not detailed
- Selection Yes
Level of evidence,
impact on patient
outcome
-
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Topic
papers
Bonow et al.
(2005)
Yes
Public health
relevance,
quality gap,
costs
More than
one guideline
No No Yes Yes
Not detailed
Yes Selection Yes
Grade of
recommendation,
relevance for the topic
No
Burge et al.
(2007)
Yes
Public health
relevance,
quality gap
Unclear No No Yes No No Selection Yes
Potential for
improvement,
meaningful, valid,
reliable, adjustable,
feasible
No
Campbell et
al. (1999)
Yes
Public health
relevance,
substantial
amount of
workload in
general practice
Guidelines
and other
sources
No No No No Yes Unclear - No
Desch et al.
(2008)
No Guidelines
and other
sources
Yes
Profession
involved in the
selected
healthcare
process
No Unclear No Yes Selection Yes
Impact on patient
outcome, potential for
improvement, feasibility
of data collection
No
Draskovic et
al. (2008)
Yes
Variance in
quality of care
between
providers
One guideline No No No No Yes Unclear - No
Estes et al.
(2008)
Yes
Public health
relevance and
costs
Guidelines
and other
sources
No No Yes Yes
Not detailed
Yes Selection Yes
Grade of
recommendation,
relevance for the topic
No
Forbes et al.
(1997)
Yes
Public health
relevance,
individual
impact on
quality of life
One guideline No No No No Yes All - No
Giesen et al.
(2007)
Yes
Quality of care
unknown
Guidelines
and other
sources
No Yes
Applicability to
the setting,
clinical
relevance
Yes Yes
AGREE instrument
Yes Selection Yes
Relevance for the
selected topic
No
Hadorn et al.
(1996)
Yes
Public health
relevance,
individual
quality-of-life
impact, costs
One guideline No No Yes No Yes All - Yes
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Hardy and
Hadley
(1995)
No One guideline No Unclear No No Yes Unclear - No
Hermanides
et al. (2008)
Yes
Public health
relevance,
quality gap
One guideline No No No No Yes Selection No Yes
Hermens et
al. (2006)
Yes
Quality of care
unknown,
guideline
adherence
unclear
One guideline No No No No Yes All - No
James et al.
(1997)
Yes
Public health
relevance, costs,
quality gap
One guideline No No No Yes
Not detailed
Yes All - No
Kongnyuy
and van den
Broek (2008)
No Guidelines
and other
sources
No No No No Yes Unclear - No
Krumholz et
al. (2006)
Yes
Public health
relevance,
quality gap
More than
one guideline
No No Yes Yes
Not detailed
Yes Selection Yes
Grade of
recommendation
No
Lee et al.
(2003)
No Guidelines
and other
sources
No No No No Yes Unclear - No
Maclean et
al. (2004)
Yes
Public health
relevance
Guidelines
and other
sources
No No No Unclear Yes Selection Yes
Impact on patient
outcome, grade of
recommendation
No
Martirosyan
et al. (2008)
Yes
Public health
relevance,
quality of care
unknown
More than
one guideline
No No No No Yes Selection Yes
Measurability
Yes
Mourad et
al. (2007)
Yes
Public health
relevance,
quality gap
More than
one guideline
No Yes
Methodological
quality
No No Yes All - No
Nijkrake et
al. (2009)
Yes
Public health
relevance and
complexity of
the topic
One guideline No No No No Yes Selection Yes
Acceptability,
measurability
No
Ouwens et
al. (2007)
Yes
Complexity of
the process of
care
Guidelines
and other
sources
No No No No Yes Selection Yes
Impact on patient
outcome
No
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2Table 3 Characteristics of included references: Methodological approaches to topic/guideline selection and extraction of recommendations (Continued)
Ouwens et
al. (2010)
Yes
Individual
impact on
quality of life,
quality gap
Guidelines
and other
sources
No Yes
Applicability to
the setting
No No Yes All - No
Radtke et al.
(2009)
No Guidelines
and other
sources
No No No Yes
Not detailed
Yes Unclear - No
Redberg et
al. (2009)
Yes
Public health
relevance, costs,
quality gap
One guideline No No No No Yes Selection Unclear No
Schouten et
al. (2005)
Yes
Quality gap
Guidelines
and other
sources
No No No No Yes Selection No Yes
Sugarman et
al. (2003)
Yes
Quality of care
unknown,
regulatory
requirements
One guideline No No No No Yes Unclear - No
Thomas et
al. (2007)
Yes
Underutilization,
quality of care
unknown
Guidelines
and other
sources
No No Yes Yes
Not detailed
Yes Selection Yes
Grade of
recommendation, level
of evidence
No
Tu et al.
(2008)
Yes
Quality gap
Guidelines
and other
sources
No No Yes No Yes Selection Yes
Meaningful, valid and
reliable, feasible,
accountable for patient
variability, potential for
improvement,
No
van den
Boogaard et
al. (2010)
Yes
Quality gap
One guideline No Yes
Most recently
revised
guideline
available
No No Yes All - No
van Hulst et
al. (2009)
No Guidelines
and other
sources
No No No No Yes Selection Yes
Grade of
recommendations
No
Wang et al.
(2006)
Yes
Public health
relevance,
complex process
of care, quality
gap
Guidelines
and other
sources
No No Yes No No Selection Yes
Impact on patient
outcome, level of
evidence, potential for
improvement, feasibility
of data collection
No
Yazdany et
al. (2009)
Yes
Quality of care
unknown
Guidelines
and other
sources
No Yes
Methodological
quality
Yes Unclear No Selection Yes
Eligible population,
process of care
performed by
healthcare providers,
impact on patient
outcome
No
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2Table 3 Characteristics of included references: Methodological approaches to topic/guideline selection and extraction of recommendations (Continued)
Method +
topic
papers
Advani et al.
(2003)
No One guideline No No No No Yes Unclear - No
Duffy et al.
(2005)
Yes
Individual
impact on
quality of life,
quality gap
More than
one guideline
No No No No Yes Selection Yes
Level of evidence,
impact on patient
outcome, breadth of
available treatment
recommendations,
clinical utility and
appropriateness,
proportion of patients
for whom the
recommendation is
likely to be relevant
No
Golden et al.
(2008)
Yes
Public health
relevance, costs,
quality gap
Guidelines
and other
sources
Yes
Profession
involved in the
selected health
care process
No No No No Selection Yes
Level of evidence
No
Hutchinson
et al. (2003)
No More than
one guideline
No Yes
Evidence based
No Yes
Suitable for primary
care, agency responsible
for development clearly
identifiable, objectives
clearly defined,
independent review
prior to publication,
information regarding
evidence adequate and
explicit, link between
major recommendations
and underlying
evidence
Yes Selection Unclear No
Laclair et al.
(2001)
No One guideline No No Yes No Yes All - No
Wollersheim
et al. (2007)
Yes
Quality gap,
public health
relevance, sound
evidence base
Guidelines
and other
sources
Yes
Membership in a
guideline-
development
committee,
methodological
competence,
profession
involved in the
selected
healthcare
process
No No No Yes Unclear - No
QI = quality indicator; ÄZQ = Ärztliches Zentrum für Qualität in der Medizin (Agency for Quality in Medicine); AHCPR = Agency for Healthcare Policy and Research; AHRQ = Agency for Healthcare Research and
Quality; AQUA-Institute = Institute for Applied Improvement and Research in Health Care; AGREE = Appraisal of Guidelines for Research and Evaluation in Europe.
aDoes not apply to method papers;
bdoes apply if not all recommendations are extracted.
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2Table 4 Characteristics of included references: Methodological approaches to QI selection, practice test, and implementation
QI selection Additional QI development elements
Reference Panel
method
Criteria for panel
members
Panel
members
listed
a
Selected
indicators
listed
a
Sources
transparent
1
LoE
b Rating criteria Practice
test
Implementation strategy Patient
participation
Method
papers
ÄZQ (2009) Unclear Unclear - - - Yes Yes
Importance for the healthcare system,
clarity, improvability, risk for adverse
effect, evidence base, grade of
recommendation
Proposed No No
AHCPR
(1995)
No No panel method - - - No Unclear Not
mentioned
No No
AHRQ (1995) No No panel method - - - No No Included Yes
Development of data collection
software, audit and feedback
No
AQUA (2010) Modified
RAND/
UCLA
Yes
Clinical expertise,
methodological
expertise
- - - Yes Yes
Relevance, clarity, feasibility
Included Yes
Development/upgrading of
data collection software
QI selection
Baker and
Fraser (1995)
No No panel method - - - No Unclear Not
mentioned
Yes
Local development, ownership
No
Bergman
(1999)
No No panel method - - - Yes Unclear Proposed Yes
Involving key stakeholders
No
Califf et al.
(2002)
No No panel method - - - Yes Unclear Not
mentioned
Yes
Education and feedback
No
Campbell et
al. (2002)
Other Unclear - - - No Unclear Not
mentioned
No No
Graham et
al. (2009)
Other No - - - No Yes
Grade of recommendation, level of
evidence, measurability, improvability
Included Yes
Audit and feedback
No
Spertus et al.
(2005)
No No panel method - - - No Yes
Useful in improving patient outcomes,
measure design, measure
implementation, overall assessment
Not
mentioned
No No
Topic
papers
Bonow et al.
(2005)
Other No Yes Yes Yes Yes Yes
Useful in improving patient outcomes,
measure design, measure
implementation, overall assessment
Not
mentioned
Yes
Defining challenges to
implementation for each QI
No
Burge et al.
(2007)
Modified
RAND/
UCLA
Yes
Members of
specialist societies
Yes Yes In part No No Proposed No No
Campbell et
al. (1999)
Modified
RAND/
UCLA
Yes
Clinical expertise,
members of
specialist societies
No Yes In part Yes No Not
mentioned
Yes No
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2Table 4 Characteristics of included references: Methodological approaches to QI selection, practice test, and implementation (Continued)
Desch et al.
(2008)
Other Yes
Members of
specialist
societies,
methodological
expertise
Yes Yes Yes No No Not
mentioned
Yes
Integration in nationwide
quality-improvement programs
No
Draskovic et
al. (2008)
Modified
RAND/
UCLA
Yes
Clinical expertise
No Yes Yes No Yes
Face validity
Included Yes
Including the informal
caregivers’ perspective
No
Estes et al.
(2008)
Other No Yes Yes Yes Yes Yes
Useful to improve patient outcomes,
measure design, measure
implementation, overall assessment
Not
mentioned
Yes
Defining challenges to
implementation for each QI
No
Forbes et al.
(1997)
No No panel method No panel
method
Yes Yes No No Included Yes
Pilot testing
No
Giesen et al.
(2007)
Other Unclear No Yes In part No Yes
Relevance, utility for evaluation of care
Included No No
Hadorn et al.
(1996)
Unclear No No Yes In part No Unclear Not
mentioned
No No
Hardy and
Hadley
(1995)
Unclear Unclear No No Yes No No Not
mentioned
No No
Hermanides
et al. (2008)
Other Yes
Clinical expertise
Yes Yes Yes Yes Yes
Appropriateness
Included No No
Hermens et
al. (2006)
Modified
RAND/
UCLA
Yes
Clinical expertise
Yes Yes Yes No Yes
Professional quality, organisational
quality, patient-oriented quality
Included Yes
Practice test
QI selection
James et al.
(1997)
Other Yes
Clinical expertise
No Yes Yes Yes Yes
Educational appropriateness, clinical
importance, measurement feasibility
Not
mentioned
No No
Kongnyuy
and van den
Broek (2008)
Other Yes
Clinical expertise,
laypersons
No Yes In part No No Planned Yes
Involving all grades of health
professionals during the whole
development process
QI selection
Krumholz et
al. (2006)
Other Yes
Clinical expertise,
methodological
expertise
members of
specialist societies
Yes Yes Yes Yes Yes
Useful in improving patient outcomes,
measure design, measure
implementation, overall assessment
Not
mentioned
Yes
Defining challenges to
implementation for each QI
No
Lee et al.
(2003)
Other Yes
Clinical expertise
Yes Yes In part No Yes
Meaningfulness, usefulness, potential for
improvement, impact on patient
outcomes, feasibility of data collection
Not
mentioned
No No
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2Table 4 Characteristics of included references: Methodological approaches to QI selection, practice test, and implementation (Continued)
Maclean et
al. (2004)
Modified
RAND/
UCLA
Yes
linical expertise,
methodological
expertise
members of
specialist societies
Yes Yes No Yes Unclear Not
mentioned
No No
Martirosyan
et al. (2008)
Modified
RAND/
UCLA
Yes
Clinical expertise,
methodological
expertise
members of
specialist societies
No Yes In part No Unclear Included No No
Mourad et
al. (2007)
Modified
RAND/
UCLA
Yes
Clinical expertise,
methodological
expertise
No Yes Yes Yes Unclear Proposed Yes
Practice test
No
Nijkrake et
al. (2009)
Other Yes
Clinical expertise,
methodological
expertise
No No Yes Yes Yes
Relevance (effectiveness, efficiency,
acceptability, measurability)
Included Yes
Training in the correct use of
the respective guideline
No
Ouwens et
al. (2007)
Modified
RAND/
UCLA
Yes
Clinical expertise
No Yes In part No Yes
Clinically relevant to patients’ health
benefits and/or to the continuity and
coordination of care
Included Yes
Practice test
QI selection
Ouwens et
al. (2010)
Other Yes
Patient
representatives
No Yes In part No Unclear Included Yes
Patient participation
QI selection
Radtke et al.
(2009)
Other Yes
Clinical expertise,
methodological
expertise, patients
No Yes In part No Yes
Inclusion in the research literature,
measurable under routine conditions,
inclusion in a certain high-quality
guideline, reproducibility, validity, clinical
relevance, sensitivity to change
Included No No
Redberg et
al. (2009)
Other Yes
Clinical expertise,
methodological
expertise
membership in
specialist societies
Yes Yes Yes Yes Yes
Useful in improving patient outcomes,
measure design, measure
implementation, overall assessment
Not
mentioned
No No
Schouten et
al. (2005)
Modified
RAND/
UCLA
Yes
Clinical expertise,
methodological
expertise
No Yes Yes Yes Yes
Clinical relevance to the patient’s health
benefit, relevance to reducing
antimicrobial resistance, relevance to
cost effectiveness
Included No No
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2Table 4 Characteristics of included references: Methodological approaches to QI selection, practice test, and implementation (Continued)
Sugarman et
al. (2003)
Other Yes
Clinical expertise,
membership in
specialist societies
No No Yes Yes Yes
Clinical importance, feasibility of
measurement, level of evidence
Included No No
Thomas et
al. (2007)
Unclear Yes
Clinical expertise,
methodological
expertise,
membership in
specialist societies
Yes Yes Yes Yes Yes
Evidence based, interpretable, actionable,
clinically meaningful, valid, reliable,
feasible
Not
mentioned
Yes
Defining challenges to
implementation for each QI
No
Tu et al.
(2008)
Other Yes
Clinical expertise,
methodological
expertise,
membership in
specialist societies
Yes Yes In part No Yes
Usefulness in improving patient
outcomes, feasibility of data collection,
reliability, validity
Not
mentioned
Yes
Pay for performance,
collaboration with national and
local initiatives, use of standard
tools, presentation at scientific
meetings, availability online
No
van den
Boogaard et
al. (2010)
Modified
RAND/
UCLA
Yes
Clinical expertise
Yes Yes Yes Yes Yes
Health gain, overall efficacy
Proposed No No
van Hulst et
al. (2009)
Modified
RAND/
UCLA
Yes
Clinical expertise,
methodological
expertise
No Yes In part Yes No Not
mentioned
Yes
Using understandable and
measurable QIs
No
Wang et al.
(2006)
Other Yes
Membership in
specialist societies
No Yes In part Yes Yes
Validity, feasibility
Not
mentioned
No No
Yazdany et
al. (2009)
Modified
RAND/
UCLA
Yes
Clinical expertise,
methodological
expertise
Yes Yes No Yes Yes
Evidence base, validity, feasibility
Proposed Yes
Assess the technical
characteristics of developed QIs
No
Method +
topic
papers
Advani et al.
(2003)
No No panel method No panel
method
No Yes No No Included No No
Duffy et al.
(2005)
Unclear Unclear No Yes Yes Yes Unclear Planned Yes
Integration in health plan
performance measurement,
quality monitoring and
accreditation programs,
integration of needed data
elements in medical
information systems
No
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2Table 4 Characteristics of included references: Methodological approaches to QI selection, practice test, and implementation (Continued)
Golden et al.
(2008)
Modified
RAND/
UCLA
Yes
Clinical expertise,
methodological
expertise,
laypersons
No No In part No Yes
Meaningfulness, quality gap,
improvability, feasibility of data collection
Included Yes
Transparency during the
development process,
providing the data collection
tool, submission to a national
performance measurement
program
QI selection
Hutchinson
et al. (2003)
Other Yes
Clinical expertise
No Yes In part Yes No Not
mentioned
No No
Laclair et al.
(2001)
Other Yes
Clinical expertise,
methodological
expertise
No No Yes Yes No Included No No
Wollersheim
et al. (2007)
Modified
RAND/
UCLA
Yes
Clinical expertise,
methodological
expertise
No Yes In part Unclear No Included Yes
Periodic audits
No
QI = quality indicator; ÄZQ = Ärztliches Zentrum für Qualität in der Medizin (Agency for Quality in Medicine); AHCPR = Agency for Healthcare Policy and Research; AHRQ = Agency for Healthcare Research and
Quality; AQUA-Institute = Institute for Applied Improvement and Research in Health Care.
aDoes not apply to method papers;
bLoE = Level of evidence (reported for underlying recommendations of the QI).
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2￿ member of a guideline development committee,
￿ having methodological competence,
￿ belonging to a profession involved in the selected
healthcare process.
Extraction of recommendations
Nine studies extracted all recommendations from
selected guidelines. In 25 studies, recommendations
were selected during the extraction process and not all
recommendations were extracted as potential QIs. Cri-
teria for this selection were reported in 21 of the 25 stu-
dies. Criteria for the preselection at the stage of
recommendation extraction mentioned by the Agency
for Healthcare Research and Quality (AHRQ) are
￿ the size of the impact on patient health (the AHRQ
considers the impact great when an issue affects a few
patients severely or affects many patients),
￿ the relevance to obtaining value for money.
Other criteria for the preselection formulated by
Hadorn et al. [39] are
￿ the importance to quality of healthcare provided,
￿ the feasibility of monitoring.
Other frequently reported criteria were the level of
evidence, the grade of recommendation, and
measurability.
Levels of evidence and grades of recommendation of
the recommendations potential QIs were developed
from were reported in 24 studies. Only four studies
reported criteria for the selection of persons who
extracted potential QIs from guidelines. They were simi-
lar to those for persons involved in guideline selection
(see above); both tasks were usually carried out by the
same group of people.
The AHRQ [24] provides a detailed description of the
extraction process, including specifications of partici-
pants’ necessary skills, as well as criteria for the selec-
tion of recommendations to be extracted.
Four requirements for persons involved in the extrac-
tion of potential QIs from guidelines postulated by the
AHRQ are
￿ clinician and nonclinician management skills,
￿ clinical expertise,
￿ technical expertise in performance measurement,
￿ healthcare information management expertise.
Another prerequisite for a valid extraction process
mentioned in several of the relevant studies requires
that the extraction be performed by at least two
researchers independently [25,37-39].
QI selection
In 35 studies, a consensus method was used to augment
the evidence from literature with expert and layperson
opinion by letting a panel rate and select a set of final
QIs from a set of potential QIs. In 15 of these 35
Figure 3 Methodological variability of guideline-based QI development.
Kötter et al. Implementation Science 2012, 7:21
http://www.implementationscience.com/content/7/1/21
Page 17 of 22publications this method was described as the “modified
RAND/UCLA method,” named after the RAND/UCLA
(University of California, Los Angeles) appropriateness
method [68].
Whereas only a few studies named the individual
members of the panels, criteria for their selection (e.g.,
clinical expertise, methodological expertise, membership
in a specialist society) were reported in 31 of 35 studies.
Only 25 of 35 studies provided rating criteria for the
panel process. Among the frequently named criteria
were the usefulness of QIs for improving patient out-
comes, their relevance, and the feasibility of monitoring.
Participation of patients in the development process
was reported in six studies. In all of these studies,
patients participated in thep a n e l s .N os t u d yr e p o r t e d
patient participation during guideline selection and the
extraction of recommendations.
Practice test
Only 19 studies reported the conduct of a QI practice
test. In two studies, the practice test was conducted
after the development process was completed. In 21 stu-
dies, a practice test was not mentioned at all.
Implementation
An implementation strategy for guideline-based QIs was
reported in 26 studies. Among the reported activities
were the instruction of key persons ("early adopters”)a s
multipliers, the participation of end users in the devel-
opment process, the publication of developed QIs by
medical associations, supplying the appropriate software,
and the adaptation of “global” QIs to more specific set-
tings. Financial incentives and certification were also
used to support implementation.
Discussion
Topic selection
Authors tended to describe the process of topic selec-
tion in insufficient detail. Mostly, selection criteria
merely reflected the aims of the application of QIs in
general: to measure and improve quality in areas of
healthcare where the actual quality of care is either sub-
optimal or unknown.
Guideline selection
The selected literature describes two different
approaches to guideline selection. The first approach
identified in the reviewed literature is to develop QIs
based on one or only a few preselected guidelines, often
with the aim of supporting or evaluating guideline
implementation. In certain contexts, such as specific set-
tings in small healthcare systems, only one guideline
may be available for QI development. In these cases,
guideline-selection processes are of no or only minor
relevance, and the number of recommendations to be
translated into potential QIs is proportionately low.
The second approach is to select a clinical topic and,
subsequently, to obtain suitable, topic-specific guidelines
as a basis for the development of QIs from guideline
recommendations. In this case, expert opinion and exist-
ing QI sets are sometimes used as alternative sources for
QIs. In comparison to the first approach, this approach
provides a broader basis for the subsequent develop-
ment of QIs, bears the potential to produce a balanced
set of QIs, carries a reduced risk of selection bias, and
increases content validity.
Many studies do not describe their guideline-selection
criteria in sufficient detail and lack critical appraisal of
their selected guidelines, both of which may compro-
mise content validity and hence the quality of resulting
QI sets. We argue that high-quality QIs can only be
derived from high-quality guidelines. To ensure QIs ori-
ginate from a sound foundation, development commit-
tees should (a) conduct a systematic search for relevant
guidelines in national and international guideline data-
bases as well as conventional literature databases and
(b) conduct a critical appraisal of the methodological
quality of selected guidelines (e.g., by using the AGREE
instrument) [67].
As is common practice in other areas of research such
as guideline development, the documentation of selec-
tion criteria for participating persons as well as the dis-
closure of their names and potential conflicts of interest
could greatly add transparency to the whole develop-
ment process and, as a result, increase the content valid-
ity of QIs.
Extraction of recommendations
The main focus of this review is the extraction of guide-
line recommendations. This step is both crucial and
unique to guideline-based QI development, whereas the
other steps could also be applied to the development of
QIs from other sources such as primary literature or
existing QI sets. We only included studies that provided
a detailed description of the recommendation-extraction
process. As a result, we excluded a large number of
otherwise eligible studies (see Additional file 4: Table 4
for a list of studies excluded for this reason).
The reviewed literature describes two different
approaches to the extraction of guideline recommenda-
tions. The first approach is to initially extract all recom-
mendations and to then select QIs using a systematic
consensus process. The second approach is to select a
limited number of recommendations during the extrac-
tion process. We believe thed i f f e r e n c eb e t w e e nb o t h
approaches is of crucial importance to the quality of
ensuing QI sets. Predominantly, only a small number of
persons conduct the extraction process. Often, those
Kötter et al. Implementation Science 2012, 7:21
http://www.implementationscience.com/content/7/1/21
Page 18 of 22participants were not selected following transparent
selection criteria. The extraction of potential QIs itself
through this small group of participants usually does
not follow any documented selection criteria, either. As
a result, the final QI set may suffer from selection bias.
Subsequent systematic consensus processes to rate
and select the extracted potential QIs are usually con-
ducted by larger panels. In comparison to the small
group of persons conducting the selection of potential
QIs, panel participants are commonly selected to build a
balanced panel of different professionals participating in
the process of healthcare the QIs are developed for. In
addition, the use of predesigned forms containing rating
and selection criteria during these systematic consensus
processes substantially reduces the risk of selection bias
(see “QI selection”).
Another important aspect of the extraction process is
the translation of the guideline text into recommenda-
tions manageable as potential QIs. It can be difficult to
derive appropriate numerators and denominators on the
basis of the guideline recommendation wording, which
may not be specific enough for this purpose. A whole
paragraph of guideline text, for instance, cannot easily
be translated into a potential QI without cutting out
potentially relevant information. Thus, the translation
process is a further potential source of bias.
Hence, both the selection of participants as such and
the documentation of selection criteria for participants
are of great importance. We identified a large deficit in
the existing literature regarding this: Only five studies
reported selection criteria for participants.
QI selection
Panel methods are not specific to guideline-based QI
development and are frequently used to systematically
augment the evidence from guidelines with expert opi-
nion (e.g., the widely used RAND/UCLA appropriateness
method [68,69]). Performed carefully, this reduces the
risk of unintentional influence of stakeholders on the
results of the development process [70]. Panel methods
are an established component of the development pro-
cess of high-quality guidelines. As our results confirm,
they are also widely used in the development of QIs
[65]. Many of the reviewed studies showed a lack of
transparency regarding the nomination process (e.g., in
not providing explicit selection criteria for panel
members).
Our results show that patient participation during QI
development is extremely uncommon. In principle, the
frequently used panel method offers room for the parti-
cipation of patients or patient representatives. However,
to date, no standardized approach to patient participa-
tion during QI development exists. To fill this gap, our
working group is currently conducting a systematic
review of approaches to patient participation during QI
development.
Practice test
Practice tests prior to publication and usage of QIs are
an essential step in evaluating validity, reliability, feasi-
bility, and other important attributes of QIs (see Back-
ground). They are an integral part of any
implementation strategy and an essential component of
the quality loop [7,26]. The practice test in a study by
Wollersheim et al. [10] showed that between 10% and
20% of the developed QIs were not measurable.
It could be argued that regular evaluations of the
usage of QIs suffice. However, given the impact QIs can
have from day one of their application (e.g., if used in
pay-for-performance models [see Background]) and the
fact that QIs are more widely accepted after an advance
test, it is desirable that practice tests under “laboratory
conditions” become established components of the
development process.
Implementation
The importance of implementation strategies is often
referred to in the course of critical appraisal of guide-
lines [42]. As for guideline development, implementation
strategies are indispensable for the real-life application
of QIs [58]. Our results show that even though a wide
variety of implementation strategies are reported, they
are not always part of the QI development process.
Given the importance of implementation, a thorough
discussion and application of implementation strategies
should be an integral part of a gold-standard QI devel-
opment method.
Strengths and limitations
To our knowledge, this is the first systematic review of
methodological approaches to guideline-based QI devel-
opment. This systematic review has been conducted fol-
lowing a rigorous methodological approach [71]. The
identification of methodological approaches to each step
of guideline-based QI development allows a detailed
description and comparison of the development meth-
ods published so far. We summarized the available evi-
dence from systematically retrieved literature to provide
a comprehensive overview of guideline-based QI
development.
A major limitation of this study is that we were not
able to provide answers to review questions 2 and 3.
The selected studies were very heterogeneous in type, in
terms of the quality of reporting and in the methodolo-
gical approaches to guideline-based QI development
presented. Because we could not identify any studies
comparing different methodological approaches to
guideline-based QI development and no gold standard
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approaches to, we were not able to provide an evidence-
based judgment on the methodological approaches iden-
tified. Hence, we were not able to determine whether
any of the methodological approaches (as a whole or as
single development steps) is “superior” to the others in
its ability to generate high-quality QIs.
However, in describing the methodological approaches
used by the different working groups developing QIs, we
provide a basis for further research. This research
should seek to determine which of these methodological
approaches applied to individual steps of the develop-
ment process are best suited to constitute a develop-
ment pathway that generates the “best” QIs. In order to
achieve this aim in view of limited resources, existing
guideline developers network infrastructure (e.g., the G-
I-N) should be used to cooperate and formulate a gold
standard, as proposed by Blozik et al. [20].
Conclusions
A wide variety of methodological approaches are
described in the literature for guideline-based QI devel-
opment. It remains unclear which method leads to the
best QIs, since no randomized controlled or other com-
parative studies investigating this issue exist.
In presenting a comprehensive methodological over-
view, we provide a groundwork for further research
leading to an evidence-based gold standard for guide-
line-based QI development.
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